Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2026年2月24-26日
日本, 東京, Grand Nikko Tokyo Daiba

主要会议第2天

主要会议第2天
7:45am - 8:10am25 分
Main Conference
主要会议
Registration and Coffee
报到与咖啡时光
    8:10am - 8:15am5 分
    Main Conference
    主要会议
    Chairperson’s Remarks
    议长致辞
      8:15am - 8:45am30 分
      Main Conference
      主要会议
      Learn How Electrostatic Drying Technology Can Help
      了解静电干燥技术的优势
      • Keith Cronce - Chief Operating Officer, Fluid Air, A Division of Spraying Systems
      Concurrent Tracks
      8:45am - 9:15am30 分
      Oligonucleotide CMC
      寡核苷酸CMC
      Characterization of Partially Phosphorothiolated Oligonucleotides: Analytical Strategies for CMC Support
      • Leo Joyce, PhD - Director, Analytical Department, Arrowhead Pharmaceuticals
      8:45am - 9:15am30 分
      mRNA Advances Track
      mRNA进步分会
      Chemical Synthesis of mRNAs Based on Efficient Capping Reaction
      基于高效加帽反应的mRNA化学合成
      • Hiroshi Abe, PhD - Professor, Department of Chemistry, Graduate School, Nagoya University
      9:15am - 9:45am30 分
      Oligonucleotide CMC
      寡核苷酸CMC
      A Deep Dive into Detritylation Making it Safer and Sustainable
      • Yogesh Sanghvi, PhD - President, Rasayan Inc.
      9:15am - 9:45am30 分
      mRNA Advances Track
      mRNA进步分会
      Advancing Oligonucleotide and mRNA Therapeutics: TUG1 ASO for Recurrent Glioblastoma and Runx1 mRNA for Knee Osteoarthritis
      寡核苷酸・mRNA医药进步：治疗复发性胶质母细胞瘤的TUG1 ASO和治疗膝骨关节炎的Runx1 mRNA
      • Shiro Akinaga, PhD - President and CEO, NANO MRNA, Co., Ltd.
      9:45am - 10:15am30 分
      Oligonucleotide CMC
      寡核苷酸CMC
      Redefining standards: empowering sustainable synthesis
        9:45am - 10:15am30 分
        mRNA Advances Track
        mRNA进步分会
        Advances in mRNA-based Therapeutics for Protein Replacement
        基于mRNA蛋白质替代疗法的进步
        • Pad Chivukula, PhD - Chief Scientific Officer and COO, Arcturus Therapeutics
        10:15am - 10:55am40 分
        Networking Refreshment Break with Poster and Exhibit Viewing
        社交茶歇 （包含参观海报/展览）
        Networking Refreshment Break with Poster and Exhibit Viewing
        社交茶歇 （包含参观海报/展览）
          10:20am - 10:35am15 分
          TIDES Talks in the Exhibit Hall
          展廳的TIDES演講
          Navigating the Next Phase: Real-World Lessons in Oligo Development
          • Alun Garner - Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies
          Concurrent Conference Tracks
          同时举行的会议分会
          10:55am - 11:00am5 分
          Oligonucleotide Track
          寡核苷酸分会
          Chairperson’s Remarks: Track 1
          议长致辞：分会1
            10:55am - 11:00am5 分
            Peptide Track
            胜肽分会
            Chairperson’s Remarks: Track 2
            议长致辞：分会2
              11:00am - 11:30am30 分
              Oligonucleotide Track
              寡核苷酸分会
              Formulation Innovations for Future Oligonucleotide Therapies: Insights Inspired by Biologics
              未来寡核苷酸疗法上的配方创新：受生物制剂启发的见解
              • Tomoya Takenaka, PhD - Principal Scientist, Drug Product and Device Development, Takeda Pharmaceutical Company
              11:00am - 11:30am30 分
              Peptide Track
              胜肽分会
              De Novo Discovery of Potent Peptidomimetics by Diverse Genetic Code Reprogramming
              通过多种遗传密码重编程重新发现有效的肽模拟物
              • Maxwell Sigal - Ph.D. Candidate, Lab of Prof. Hiroaki Suga, The University of Tokyo
              11:30am - 12:00pm30 分
              Oligonucleotide Track
              寡核苷酸分会
              Insights into siRNA Duplex Stability and Formulation Screening by UV-Vis and Rapid-screening DSC Thermal Analyses
              透过紫外可见光和快速筛选 DSC 热分析深入了解 siRNA 双链体稳定性和配方筛选
              • Molly Blevins, PhD - Principal Scientist, Genentech
              11:30am - 12:00pm30 分
              Peptide Track
              胜肽分会
              R2R01: A Potent RXFP1 Peptide Agonist in Phase 2 Clinical Development for Cardiorenal Conditions
              • Federica Tucci - Principal Research Scientist, IRBM
              12:00pm - 12:30pm30 分
              Oligonucleotide Track
              寡核苷酸分会
              Achieving Quality and Regulatory Confidence in Oligo Therapeutics with Advanced Purification
              透过先进纯化技术实现寡核苷酸医药品质和监管信心
              • Alun Garner - Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies
              12:00pm - 12:30pm30 分
              Peptide Track
              胜肽分会
              Late Breaking Presentation
              最新简报
                12:30pm - 1:40pm70 分
                Oligonucleotide Track
                寡核苷酸分会
                Networking Luncheon with Poster and Exhibit Viewing
                交流午餐会 （包含参观海报/展览）
                  12:30pm - 1:40pm70 分
                  Peptide Track
                  胜肽分会
                  Networking Luncheon with Poster and Exhibit Viewing
                  交流午餐会 （包含参观海报/展览）
                    Concurrent Tracks
                    1:40pm - 1:45pm5 分
                    Oligonucleotide Track
                    寡核苷酸分会
                    Chairperson’s Remarks: Track 1
                    议长致辞：分会1
                      1:40pm - 1:45pm5 分
                      Peptide Track
                      胜肽分会
                      Chairperson’s Remarks: Track 2
                      议长致辞：分会2
                      • Ved Srivastava, PhD - CTO, Perpetual Medicines
                      1:45pm - 2:15pm30 分
                      Oligonucleotide Track
                      寡核苷酸分会
                      Understanding UF/DF Capabilities for Enhancing ASO Processing to Make a Liquid or Lyo API
                      了解超滤/去膜功能在液态或冷冻干燥API生产中增强反式氧化制程 (ASO) 的作用
                      • Robert Gronke, PhD - Senior Principal Scientist, Biogen, Inc
                      1:45pm - 2:15pm30 分
                      Peptide Track
                      胜肽分会
                      Switching off Transcription Factors Using Intracellular Library-derived Peptides
                      利用胞内文库衍生胜肽关闭转录因子
                      • Jody Mason, PhD - Professor of Biochemistry, University of Bath
                      2:15pm - 2:45pm30 分
                      Oligonucleotide Track
                      寡核苷酸分会
                      Oligo CMC Presentation
                      OligoCMC简报
                        2:15pm - 2:45pm30 分
                        Peptide Track
                        胜肽分会
                        Mixed-Chirality Prohibitin Peptides Enhance Stability and In Vivo Effects on Obesity
                        透过混合手性抑制胜肽提高稳定性并增强体内抗肥胖功效
                        • David Craik, PhD - Professor of Biomolecular Structure, University of Queensland
                        2:45pm - 3:15pm30 分
                        Oligonucleotide Track
                        寡核苷酸分会
                        Challenges of Raw Material Acquisition for Oligonucleotide Synthesis
                        寡核苷酸合成上原料采购的课题
                        • Long Ma, PhD - CEO and Chief Scientist, Orilife Biotech
                        2:45pm - 3:15pm30 分
                        Peptide Track
                        胜肽分会
                        Selection of Constrained Peptides as Functional Modulators of CB2R and Characterization of Functional Effects in IBD Models
                        作为CB2R功能调节剂的约束肽之选择与IBD模型中功能效应的表征
                        • David O'Connell, PhD - Professor, School of Biomolecular & Biomedical Science, University College Dublin
                        3:15pm - 3:45pm30 分
                        Oligonucleotide Track
                        寡核苷酸分会
                        Networking Refreshment Break with Poster and Exhibit Viewing
                        社交茶歇 （包含参观海报/展览）
                          3:15pm - 3:45pm30 分
                          Peptide Track
                          胜肽分会
                          Networking Refreshment Break with Poster and Exhibit Viewing
                          社交茶歇 （包含参观海报/展览）
                            Concurrent Tracks
                            3:45pm - 4:15pm30 分
                            Oligonucleotide Track
                            寡核苷酸分会
                            Development and Manufacture of Oligonucleotides via Enzymatic Ligation
                            透过酵素连接技术开发和生产寡核苷酸
                            • Scott May, PhD - VP of Chemistry, Synthetic Molecule Design & Development, Eli Lilly and Company
                            • Arne Berthelmann - Senior Director Oligonucleotide R&D, Bachem AG
                            3:45pm - 4:15pm30 分
                            Peptide Track
                            胜肽分会
                            Applying PeptiDream’s Peptide Discovery Platform System (PDPS) to Identify and Optimize Oral IL-17 Peptide Inhibitors for Psoriasis
                            透过PeptiDream的药物发现和开发平台（PDPS）可识别和优化用于治疗干癣的口服 IL-17 胜肽抑制剂
                            • Haruaki Kurasaki, PhD - Director, Medicinal Chemistry, PeptiDream
                            4:15pm - 4:45pm30 分
                            Oligonucleotide Track
                            寡核苷酸分会
                            Technology and Innovation in Oligonucleotide CMC
                            寡核苷酸CMC上的技术与创新
                            • Masafumi Iwamoto, PhD - Associate Director of Technology and Innovation, Nitto Denko Avecia
                            4:15pm - 4:45pm30 分
                            Peptide Track
                            胜肽分会
                            Harnessing Venom for Drug Discovery: Developing a High-Performance Venom Library Platform with a Machine Learning-Enabled Rapid Hit-to-Lead Workflow
                            活用Venom进行药物发现：利用ML支援的快速先导化合物制程，开发高性能Venom库平台
                            • Yingnan Zhang, PhD - Senior Principal Scientific Manager, Genentech
                            4:45pm - 5:15pm30 分
                            Oligonucleotide Track
                            寡核苷酸分会
                            Lessons Learned Building an Oligo CMC Program for a Small Company: Doing More with Less
                            为小型企业建立寡核苷酸 CMC 计划的经验教训：事半功倍
                            • Pablo Lores Lareo, PhD - CMC Director, Sylentis
                            4:45pm - 5:15pm30 分
                            Peptide Track
                            胜肽分会
                            Antibody Peptide Conjugates: The Next Big Modality?
                            APC：一种有前景的模式？
                            • Kerry Blanchard, MD, PhD - CEO, Chairman and Founder, Perpetual Medicines
                            5:15pm - 6:15pm60 分
                            Oligonucleotide Track
                            寡核苷酸分会
                            Networking Cocktail Reception with Poster and Exhibit Viewing
                            社交鸡尾酒会 （包含参观海报/展览）
                              5:15pm - 6:15pm60 分
                              Peptide Track
                              胜肽分会
                              Networking Cocktail Reception with Poster and Exhibit Viewing
                              社交鸡尾酒会 （包含参观海报/展览）
                                6:15pm - 6:20pm5 分
                                Oligonucleotide Track
                                寡核苷酸分会
                                Close of Day Two
                                第2天结束
                                  6:15pm - 6:20pm5 分
                                  Peptide Track
                                  胜肽分会
                                  Close of Day Two
                                  第2天结束

                                    * 活动内容有可能不事先告知作更动及调整。

                                    会前研讨会（上午） & 主要会议第1天（下午）
                                    Next 主要会议第3天